







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 3,178 | $3.18 | 10.1 | 352.2 | 0.00 | 0.00 | 512.969 | |
![]() | ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 44,400 | $3.18 | 141.2 | 352.2 | 0.00 | 0.00 | 512.969 | |
![]() | ECYT | Endocyte, Inc. | SANDERLING VENTURES MANAGEMENT | 10% Owner | 2011-12-21 | Buy | 4,400 | $3.18 | 14 | 352.2 | 0.00 | 0.00 | 512.969 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Jim Simons | 2013-03-31 | 97,100 | 0% | -48.2% | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments